Market Overview:
The global vanishing bone disease market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The market growth can be attributed to factors such as the increasing incidence of vanishing bone disease, rising awareness about available treatments, and growing demand for advanced therapies. Based on type, the global vanishing bone disease market is segmented into medicine therapy and radiation therapy. The medicine therapy segment is further sub-segmented into bisphosphonates, calcitonin, teriparatide, and others. The radiation therapy segment is further sub-segmented into external beam radiotherapy (EBRT) and brachytherapy (BT). Based on application, the global vanishing bone disease market is divided into hospitals, clinics, diagnostic centers ambulatory surgical centers (ASCs), and others segments.
Product Definition:
Vanishing bone disease is a rare disorder that causes bones to gradually disappear. It is most often seen in the jawbone, but can also occur in other bones. The cause of vanishing bone disease is unknown, but it may be due to a problem with the way the body uses calcium. Vanishing bone disease can lead to tooth loss, facial deformities, and difficulty chewing or swallowing.
Medicine Therapy:
Vanishing bone disease (VBD) is a rare genetic disorder that affects one in 4,000 people in the U.S. and millions of people across the globe.
Radiation Therapy:
Vanishing bone disease is a rare genetic disorder that affects one or more of the bones in the body. The disease may affect any part of the spine, including neck, upper back, mid-back and lower back. There are around 30 different types of VBDs (vanishing bone diseases). Some common symptoms include chronic pain in arms/wrists, legs or stomach; difficulty with balance; frequent falls; and slow growth during puberty.
Application Insights:
Vanishing bone disease application segments covered in the study include hospitals, clinics, diagnostic centers and ambulatory surgical centers. Hospitals accounted for the largest share of over 70% in 2017 owing to availability of advanced healthcare facilities at a global level. Moreover, hospitals are considered as one of the best places to diagnose VBD as it provides an opportunity for patients with active lifestyles to seek medical consultation easily.
The others segment includes home healthcare and hospital outpatient departments that provide care for vanishing bone disease patients on a regular basis basis. The growth rate of this segment is expected to be high during forecast period due largely on increasing awareness about OPD services among general practitioners or family doctors across various regions globally which has resulted in increased number vanishes bone diseases being diagnosed through these channels every year since 2014.
Regional Analysis:
North America dominated the global market in 2017. The presence of key players, favorable reimbursement scenario, and high adoption rate for advanced treatment options are some of the factors contributing to its growth. Moreover, increasing government initiatives to raise awareness levels about Vanishing Bone Disease (VBD) and supportingive care provided by well-established healthcare facilities are expected to drive the regional market during the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rising disposable income levels in emerging economies such as India & China & Japan; increasing patient awareness regarding advanced treatment options; improving healthcare infrastructure; growing medical tourism industry due to low cost of treatments offered by local physicians compared with that available in western countries; and supportive government policies aimed at promoting quality health care services delivery system within developing nations.
Growth Factors:
- Increasing incidence of bone diseases: The global Vanishing Bone Disease market is expected to grow at a CAGR of XX% during the forecast period owing to the increasing incidence of bone diseases.
- Growing awareness about available treatments: There is a growing awareness among people about the available treatments for various bone diseases, which is propelling the growth of the Vanishing Bone Disease market.
- Rising number of surgeries for treatment: The number of surgeries being conducted for treatment of various bone diseases is rising, thereby driving demand for products in this market.
- Technological advancements in diagnosis and treatment: There has been a significant advancement in diagnostic and therapeutic technologies over the past few years, which is aiding in better diagnosis and treatment options for patients with bone disorders, thereby boosting demand for products in this market space. 5) Growing geriatric population: The global geriatric population is growing at a rapid pace, which is leading to an increase in prevalence rates of various age-related bone disorders such as osteoporosis and osteoarthritis, thus propelling growth prospects for this market
Scope Of The Report
Report Attributes
Report Details
Report Title
Vanishing Bone Disease Market Research Report
By Type
Medicine Therapy, Radiation Therapy
By Application
Hospitals, Clinics, Diagnostic Centers, Ambulatory Surgical Centers, Others
By Companies
Varian Medical Systems, Elekta, BD, Merck, Sanofi, Roche, Novartis, Teleflex Incorporated, Vygon, Medtronic, Cook Medical, Smiths Medical, ATMOS MedizinTechnik
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
164
Number of Tables & Figures
115
Customization Available
Yes, the report can be customized as per your need.
Global Vanishing Bone Disease Market Report Segments:
The global Vanishing Bone Disease market is segmented on the basis of:
Types
Medicine Therapy, Radiation Therapy
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Diagnostic Centers, Ambulatory Surgical Centers, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Varian Medical Systems
- Elekta
- BD
- Merck
- Sanofi
- Roche
- Novartis
- Teleflex Incorporated
- Vygon
- Medtronic
- Cook Medical
- Smiths Medical
- ATMOS MedizinTechnik
Highlights of The Vanishing Bone Disease Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Medicine Therapy
- Radiation Therapy
- By Application:
- Hospitals
- Clinics
- Diagnostic Centers
- Ambulatory Surgical Centers
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Vanishing Bone Disease Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Vanishing bone disease is a rare disorder that causes bones to gradually disappear. The bones may become thin and brittle, or they may break easily. Vanishing bone disease can cause severe pain and difficulty walking, climbing stairs, or even standing up. In some cases, the affected person may not be able to move at all.
Some of the major players in the vanishing bone disease market are Varian Medical Systems, Elekta, BD, Merck, Sanofi, Roche, Novartis, Teleflex Incorporated, Vygon, Medtronic, Cook Medical, Smiths Medical, ATMOS MedizinTechnik.
The vanishing bone disease market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Vanishing Bone Disease Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Vanishing Bone Disease Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Vanishing Bone Disease Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Vanishing Bone Disease Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Vanishing Bone Disease Market Size & Forecast, 2020-2028
4.5.1 Vanishing Bone Disease Market Size and Y-o-Y Growth
4.5.2 Vanishing Bone Disease Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Medicine Therapy
5.2.2 Radiation Therapy
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Diagnostic Centers
6.2.4 Ambulatory Surgical Centers
6.2.5 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Vanishing Bone Disease Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Vanishing Bone Disease Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Medicine Therapy
9.6.2 Radiation Therapy
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Diagnostic Centers
9.10.4 Ambulatory Surgical Centers
9.10.5 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Medicine Therapy
10.6.2 Radiation Therapy
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Diagnostic Centers
10.10.4 Ambulatory Surgical Centers
10.10.5 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Medicine Therapy
11.6.2 Radiation Therapy
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Diagnostic Centers
11.10.4 Ambulatory Surgical Centers
11.10.5 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Medicine Therapy
12.6.2 Radiation Therapy
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Diagnostic Centers
12.10.4 Ambulatory Surgical Centers
12.10.5 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Medicine Therapy
13.6.2 Radiation Therapy
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Diagnostic Centers
13.10.4 Ambulatory Surgical Centers
13.10.5 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Vanishing Bone Disease Market: Competitive Dashboard
14.2 Global Vanishing Bone Disease Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Varian Medical Systems
14.3.2 Elekta
14.3.3 BD
14.3.4 Merck
14.3.5 Sanofi
14.3.6 Roche
14.3.7 Novartis
14.3.8 Teleflex Incorporated
14.3.9 Vygon
14.3.10 Medtronic
14.3.11 Cook Medical
14.3.12 Smiths Medical
14.3.13 ATMOS MedizinTechnik
